Anteris Technologies Global Corp. (NASDAQ:AVR) Short Interest Update

Anteris Technologies Global Corp. (NASDAQ:AVR) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 1,580,000 shares, an increase of 60.2% from the September 15th total of 986,000 shares. Based on an average trading volume of 170,200 shares, the days-to-cover ratio is currently 9.3 days. Approximately 4.4% of the shares of the stock are short sold. Approximately 4.4% of the shares of the stock are short sold. Based on an average trading volume of 170,200 shares, the days-to-cover ratio is currently 9.3 days.

Institutional Investors Weigh In On Anteris Technologies Global

Several institutional investors and hedge funds have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Anteris Technologies Global by 35.2% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,744 shares of the company’s stock valued at $45,000 after purchasing an additional 3,055 shares in the last quarter. Corebridge Financial Inc. bought a new stake in shares of Anteris Technologies Global during the 1st quarter valued at about $27,000. Intech Investment Management LLC bought a new stake in shares of Anteris Technologies Global during the 2nd quarter valued at about $49,000. Deutsche Bank AG bought a new position in Anteris Technologies Global in the first quarter worth approximately $59,000. Finally, Nuveen LLC bought a new position in Anteris Technologies Global in the first quarter worth approximately $71,000.

Anteris Technologies Global Stock Up 7.1%

Shares of AVR opened at $6.35 on Wednesday. The stock’s 50-day moving average price is $4.52 and its two-hundred day moving average price is $4.07. Anteris Technologies Global has a 12 month low of $2.34 and a 12 month high of $8.79.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings results on Monday, August 11th. The company reported ($0.58) EPS for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.05). The business had revenue of $0.62 million during the quarter, compared to analysts’ expectations of $0.58 million. As a group, research analysts anticipate that Anteris Technologies Global will post -2.66 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Anteris Technologies Global in a report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $16.50.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.